Does medical marijuana work? Florida consortium seeks answers

May 9, 2023

3 min

Almut Winterstein

By Emma Richards


A consortium of nine universities in Florida, led by faculty at the University of Florida, is in the early stages of investigating the effectiveness of marijuana as a medical treatment.


Almut Winterstein, a professor at the University of Florida who also serves as the director of the Consortium for Medical Marijuana Outcomes Research, says there is promising data on pain therapy and epilepsy but much still to learn about cannabis as a medical treatment.


The Consortium for Medical Marijuana Outcomes Research is assessing the drug’s risks and benefits for different medical conditions and its safety and side effects when used alone or in conjunction with other prescription medications.


“What I can tell you is that right now there is promising and fairly solid data that supports the use of medical marijuana as an adjuvant for pain therapy,” said Almut Winterstein, a professor in the College of Pharmacy at UF who also serves as the director of the consortium. “And there’s also evidence that supports the use for certain types of epilepsy.”


As for other conditions, the impacts of medical marijuana are still unknown.

The Florida State Legislature created the consortium in 2019, four years after enacting legislation that permits use of marijuana for certain clinical conditions.


Currently, 37 states have a medical marijuana program, though the programs vary as far as how and to whom cannabis can be prescribed. But, Winterstein said, little is known about marijuana’s clinical safety and effectiveness.


“I think that the Legislature was really forward looking in creating something that supplements the research that is currently not sufficient,” she said in an episode of the From Florida Podcast.


The consortium will also gauge who is using and able to access medical marijuana and determine the benefits and drawbacks of different dosages. To do so, the group is working on three primary branches of research.


The first area is a competitive grants program that funds researchers across all participating universities.


The second branch is M3, or Medical Marijuana and Me, a new study that will track patients from their first use of medical marijuana for a year to assess their experiences.


“That will give us ideas about what type of dosage, form and product do patients eventually end up on,” Winterstein said. “That is a very empirical approach because we have no head-to-head comparison of what works better or worse, but we can capture patients’ experiences, what they think works, what doesn't, what kind of side effects they might experience and so on.”


Finally, what Winterstein calls the consortium’s “biggest baby and most important baby” is the Medical Marijuana Outcomes Research Repository, known as MEMORY. The repository will allow researchers to use de-identified dispensing data from the Department of Health to monitor health outcomes of the large population of 700,000 registered medical marijuana patients.


These data will give researchers insight on cannabis safety and effects, whether positive or negative, linking to healthcare utilization, such as hospitalization or emergency department visits.


The consortium is hosting the second annual Cannabis Clinical Outcomes Research Conference May, 19-20 in Orlando, where researchers will discuss the latest research on medical marijuana.


“We are really trying to get people interested in this topic,” Winterstein said. “And in particular making sure that they have access to objective information that really allows them to make the right decision with respect to the use of medical marijuana.”


To hear more about the consortium’s medical marijuana research, listen to the episode on From Florida at this link. Listen to other episodes in the From Florida podcast here.


Read a recent article quoting Professor Winterstein here:



Connect with:
Almut Winterstein

Almut Winterstein

Distinguished Professor

Almut Winterstein is an expert in drug safety and ways to improve medication use.

Medical MarijuanaHealthcare QualityDrug Use in Maternal and Child HealthMedical Marijuana SafetyPharmacoepidemiology
Powered by

You might also like...

Check out some other posts from University of Florida

3 min

Scientist’s cat, again, helps discover new virus

Pepper, the pet cat who made headlines last year for his role in the discovery of the first jeilongvirus found in the U.S., is at it again. This time, his hunting prowess contributed to the identification of a new strain of orthoreovirus. John Lednicky, Ph.D., Pepper’s owner and a University of Florida College of Public Health and Health Professions virologist, took Pepper’s catch — a dead Everglades short-tailed shrew — into the lab for testing as part of his ongoing work to understand transmission of the mule deerpox virus. Testing revealed the shrew had a previously unidentified strain of orthoreovirus. Viruses in this genus are known to infect humans, white-tailed deer, bats and other mammals. While orthoreoviruses’ effects on humans are not yet well understood, there have been rare reports of the virus being associated with cases of encephalitis, meningitis and gastroenteritis in children. “The bottom line is we need to pay attention to orthoreoviruses, and know how to rapidly detect them,” said Lednicky, a research professor in the PHHP Department of Environmental and Global Health and a member of UF’s Emerging Pathogens Institute. The UF team published the complete genomic coding sequences for the virus they named “Gainesville shrew mammalian orthoreovirus type 3 strain UF-1” in the journal Microbiology Resource Announcements. “There are many different mammalian orthoreoviruses and not enough is known about this recently identified virus to be concerned,” said the paper’s lead author Emily DeRuyter, a UF Ph.D. candidate in One Health. “Mammalian orthoreoviruses were originally considered to be ‘orphan’ viruses, present in mammals including humans, but not associated with diseases. More recently, they have been implicated in respiratory, central nervous system and gastrointestinal diseases.” The Lednicky lab’s jeilongvirus and orthoreovirus discoveries come on the heels of the team publishing their discovery of two other novel viruses found in farmed white-tailed deer. Given the propensity of viruses to constantly evolve, paired with the team’s sophisticated lab techniques, finding new viruses isn’t entirely surprising, Lednicky said. “I’m not the first one to say this, but essentially, if you look, you’ll find, and that’s why we keep finding all these new viruses,” Lednicky said. Like influenza virus, two different types of orthoreovirus can infect a host cell, causing the viruses’ genes to mix and match, in essence, creating a brand new virus, Lednicky said. In 2019, Lednicky and colleagues isolated the first orthoreovirus found in a deer. That strain’s genes were nearly identical to an orthoreovirus found in farmed mink in China and a deathly ill lion in Japan. How in the world, the scientific community wondered, could the same hybrid virus appear in a farmed deer in Florida and two species of carnivores across the globe? Some experts speculated that components of the animals’ feed could have come from the same manufacturer. With so many unanswered questions about orthoreoviruses and their modes of transmission, prevalence in human and animal hosts and just how sick they could make us, more research is needed, DeRuyter and Lednicky said. Next steps would include serology and immunology studies to understand the threat Gainesville shrew mammalian orthoreovirus type 3 strain UF-1 may hold for humans, wildlife and pets. For readers concerned about Pepper’s health, rest assured. He has shown no signs of illness from his outdoor adventures and will likely continue to contribute to scientific discovery through specimen collection.    “This was an opportunistic study,” Lednicky said. “If you come across a dead animal, why not test it instead of just burying it? There is a lot of information that can be gained.”

1 min

New study suggests Florida Chagas disease transmission

Researchers from the University of Florida Emerging Pathogens Institute and Texas A&M University gathered their resources to investigate the potential of vector-borne transmission of Chagas in Florida. The 10-year-long study, published in the Public Library of Science Neglected Tropical Diseases, used data from Florida-based submissions, as well as field evidence collected from 23 counties across Florida. Chagas disease is considered rare in the United States. Since it is not notifiable to most state health departments, it is quite difficult to know exactly how many cases there are and how frequently it’s transmitted. Chagas disease is caused by the protozoan parasite Trypanosoma cruzi. Nuisance blood-sucking insects known as kissing bugs spread the parasite to humans when exposure to their feces penetrates the mucus membranes, breaches the skin or gets orally ingested. Interestingly, it is believed that most companion animals, like dogs and cats, acquire the parasite from eating the kissing bug itself. The first record of kissing bugs, scientifically known as Triatoma sanguisuga, harboring T. cruzi in Florida was from an insect in Gainesville in 1988. However, kissing bugs have been calling the state home for far longer than humans have. Currently, there are two known endemic species of kissing bugs in the Sunshine State: Triatoma sanguisuga, the species invading homes, and the cryptic species Paratriatoma lecticularia, which live primarily in certain Floridan ecosystems but were not found in this study. Read more ...

2 min

UF works with Gainesville-based Peaceful Paths to educate the public about domestic abuse and cybersecurity

Domestic abuse affects millions of people every year, often in unseen and deeply personal ways, and online threats toward victims can be particularly harmful. To address this reality locally, the University of Florida’s Center for Privacy and Security for Marginalized and Vulnerable Populations, or PRISM, works with Gainesville-based domestic abuse support center Peaceful Paths to help people stay safe in the digital world. Kevin Butler, Ph.D., the director of PRISM and the Florida Institute for Cybersecurity Research at UF, has been researching issues related to security and privacy of technologies that affect survivors of intimate partner violence for years. He and his graduate students connected with Peaceful Paths in 2022, presenting their findings on cybersecurity and demonstrating how their research may help improve online safety for vulnerable populations. They developed a pilot study, a survey and interview protocols that are now helping those in need at the center. “[We aim to] develop principles of design that will allow for a robust technology design that really mitigates harms and improves benefits for all,” Butler said about PRISM. Educating abuse survivors has been a key component of the collaboration between UF and Peaceful Paths. For example, PRISM’s team has conducted research on the effects of stalkerware, also known as spyware, which is a type of software or app designed to be installed secretly on people’s devices to monitor their activities without their consent. Abusers may use this tool to track and harass victims, and stalkerware is regularly linked to domestic violence – a fact that is not widely known. "Even the first presentation [UF] gave enhanced our advocates' knowledge of security pieces, which helps them safety plan with survivors," said Peaceful Paths CEO Crystal Sorrow. “It actually increases the safety of everyone in the community we work with when we talk about red flags, digital dating abuse and healthy relationships.” While PRISM, which is supported by the National Science Foundation, is making an impact on the local community, its overall reach is much broader. PRISM was the first academic partner in the Coalition Against Stalkerware, which includes groups such as the National Network to End Domestic Violence, the Electronic Frontier Foundation, and law enforcement agencies throughout the United States and the world.

View all posts